{
    "2019-10-15": [
        [
            {
                "time": "",
                "original_text": "部分CRO&CDMO三季度业绩预告出炉，业绩分化明显 盈利能力下降",
                "features": {
                    "keywords": [
                        "CRO",
                        "CDMO",
                        "三季度",
                        "业绩预告",
                        "业绩分化",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗板块异动多只个股涨停， 业绩支撑下四类标的股获机构青睐",
                "features": {
                    "keywords": [
                        "医疗板块",
                        "异动",
                        "个股涨停",
                        "业绩支撑",
                        "机构青睐"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:关注带量采购全国扩面,聚焦核心资产",
                "features": {
                    "keywords": [
                        "医药生物",
                        "带量采购",
                        "全国扩面",
                        "核心资产"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}